Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US
July 1, 2020PLOSCOVID-19
More Projects
Beyond Reach: How Health Marketers Evaluate Data Partners
